Show simple item record

Addressing doxorubicin resistance in bone sarcomas using novel drug-resistant models

dc.contributor.authorGallego, Borja
dc.contributor.authorMurillo, Dzohara
dc.contributor.authorRey, Verónica
dc.contributor.authorHuergo, Carmen
dc.contributor.authorEstupiñán Sánchez, Óscar Rafael
dc.contributor.authorRodríguez García, Aida 
dc.contributor.authorTornin, Juan
dc.contributor.authorRodríguez González, René 
dc.date.accessioned2023-03-02T09:29:46Z
dc.date.available2023-03-02T09:29:46Z
dc.date.issued2022
dc.identifier.citationInternational Journal of Molecular Sciences, 23(12) (2022); doi:10.3390/ijms23126425
dc.identifier.urihttp://hdl.handle.net/10651/66658
dc.description.sponsorshipAgencia Estatal de investigación (AEI) [MICINN/Fondo Europeo de Desarrollo Regional (FEDER)] [PID2019-106666RB-I00]; ISCIII/FEDER [Consorcio CIBERONC CB16/12/00390]; Plan de Ciencia, Tecnologia e innovación del Principado de Asturias/FEDER [IDI/2021/000027]; Severo Ochoa predoctoral fellowships [BP-17-108, BP- 20-046]
dc.language.isoeng
dc.relation.ispartofInternational Journal of molecular sciences
dc.rights© 2022 Los autores
dc.rightsCC Reconocimiento 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceWOS:000816040400001
dc.titleAddressing doxorubicin resistance in bone sarcomas using novel drug-resistant models
dc.typejournal article
dc.identifier.doi10.3390/ijms23126425
dc.relation.projectIDMICINN/FEDER/PID2019-106666RB-I00
dc.relation.projectIDISCIII/FEDER/CB16/12/00390
dc.relation.projectIDPCTI/FEDER/IDI/2021/000027
dc.relation.projectIDSevero Ochoa/BP-17-108
dc.relation.projectIDSevero Ochoa/BP-20-046
dc.relation.publisherversionhttp://dx.doi.org/10.3390/ijms23126425
dc.rights.accessRightsopen access
dc.type.hasVersionVoR


Files in this item

untranslated

This item appears in the following Collection(s)

Show simple item record

© 2022 Los autores
This item is protected with a Creative Commons License